We found that CCNB1, TPX2, CENPF, TOP2A, MKI67, ECT2, TK1, RRM2, NUSAP1, CKS2 were overexpressed consistently in the 568 TCGA Prostate Cancer (PRAD) samples. This evidence concerns the gene CCNB1 and prostate adenocarcinoma.